See also this year's filing and all EDGAR filings for this company.
PDF Report 0001636282_2022_Spyre_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001636282, Spyre Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 98,891,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,549,000 |
| 3 | remainder_Assets | 6,486,000 |
| 4 | LiabilitiesCurrent | 20,144,000 |
| 5 | LiabilitiesNoncurrent | 4,624,000 |
| 6 | remainder_Liabilities | 1,217,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 35,465,043 |
| 9 | ResearchAndDevelopmentExpense | 55,939,988 |
| 10 | remainder_Expenses | 141,000 |
| 11 | remainder_Revenues | 12,297,468 |
| 12 | remainder_NetIncome | 42,395 |
| 13 | remainder_ComprehensiveNetIncome | -33,201 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 109,926,000 |
| 1 | Liabilities | 25,985,000 |
| 2 | Expenses | 91,546,031 |
| 3 | Revenues | 12,297,468 |
| 4 | StockholdersEquity | 83,941,000 |
| 5 | NetIncome | -79,206,168 |
| 6 | ComprehensiveNetIncome | -79,222,768 |
| 7 | BaseVar | 119,915,048 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.53 |
| 9 | EconomicCapitalRatio | 2.70 |
Edgar->Model Mapping
Feature Distribution
Change over Time
